Press
November 18, 2026
Iambic Presents Preclinical Data for CDK2/4 Inhibitor IAM-C1 and Brain-Penetrant KIF18A Inhibitor IAM217 at 2026 EORTC-NCI-AACR Symposium

Related articles
Let's work together
Leverage the Iambic discovery process for your program. Reach out to us at partnerships@iambic.ai.
Contact us


